2.54 USD
↗ 0.21 (9.01%)AT CLOSE (11:59 AM EDT)
Connect Biopharma Holdings Limited Ordinary Shares
CNTBNASDAQ • USD
2.61
↗ 0.07 (2.76%)
POST MARKET (AS OF 04:13 PM EDT)
Post Market
AS OF 04:13 PM EDT
2.61
↗ 0.07 (2.76%)
Market: OPEN
Shares of Connect Biopharma Holdings Limited Ordinary Shares (CNTB) are trading at $2.61. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation front, CNTB trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 12, 2026.
Open?$2.33
High?$2.64
Low?$2.33
Prev. Close?$2.33
Volume?801.9K
Avg. Volume?460.5K
VWAP?$2.52
Rel. Volume?1.74x
Bid / Ask
Bid?$2.16 × 100
Ask?$2.99 × 100
Spread?$0.83
Midpoint?$2.58
Valuation & Ratios
Market Cap?146.7M
Shares Out?63.0M
Float?13.7M
Float %?21.8%
P/E Ratio?N/A
P/B Ratio?3.44
EPS?-$1.03
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Employees
64
Market Cap
146.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-09-03
Address
3580 CARMEL MOUNTAIN ROAD, SUITE 200
SAN DIEGO, CA 92130
Phone: 858-727-1040
SAN DIEGO, CA 92130
Phone: 858-727-1040
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?-7.62Distress
Confidence?53%Low
Short InterestHigh
Short % of Float?15.02%High
Short Interest?2.1M
Days to Cover?8.0
Free Float13.7M
Avg Daily Volume256.8K
Settlement Date2026-07-31
Financial Health
Current Ratio?3.23Strong
Quick Ratio?3.23Strong
Cash Ratio?2.70Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?3.44FAIR▾
Peers100
S&P49
P/S?629.64HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.5CHEAP▾
S&P97
EV/Sales?432.07HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-152.3%WEAK▾
S&P3
ROA?-108.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-57605000
Enterprise Value?$100.7M
Fundamentals ratios updated end of day